Patents Assigned to SHANGHAI HANMAI BIO-PHARMA CO., LTD.
  • Opioid receptor antagonist conjugate and use thereof
    Patent number: 11311533
    Abstract: The present invention relates to an opioid receptor antagonist conjugate and a use thereof. In particular, the present invention relates to a covalent coupling conjugate of a hydrophilic polymer and an opioid receptor antagonist and the use thereof.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: April 26, 2022
    Assignee: SHANGHAI HANMAI BIO-PHARMA CO., LTD.
    Inventor: Mei He
  • OPIOID RECEPTOR ANTAGONIST CONJUGATE AND USE THEREOF
    Publication number: 20210121455
    Abstract: The present invention relates to an opioid receptor antagonist conjugate and a use thereof. In particular, the present invention relates to a covalent coupling conjugate of a hydrophilic polymer and an opioid receptor antagonist and the use thereof.
    Type: Application
    Filed: January 26, 2017
    Publication date: April 29, 2021
    Applicant: SHANGHAI HANMAI BIO-PHARMA CO., LTD.
    Inventor: Mei HE